Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A particular
monoclonal antibody used in the treatment ofCrohn's disease .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word certolizumab.
Examples
-
Separately, Astellas said it will jointly develop and market rheumatoid arthritis drug Cimzia, or certolizumab pegol, in Japan with Belgian pharmaceutical firm UCB .
Takeda Cuts Outlook, While Astellas Get Boost Kana Inagaki 2012
-
In a second study published in Clinical Gastroenterology and Hepatology, doctors found that certolizumab pegol - another type of biologic therapy - effectively maintains remission of
PhysOrg.com - latest science and technology news stories 2010
-
Doctors assessed the long-term effectiveness, safety and immunogenicity (ability to create an immune response) of five continuous versus interrupted maintenance therapy with subcutaneous certolizumab pegol in patients with Crohn's disease.
PhysOrg.com - latest science and technology news stories 2010
-
In a second study published in Clinical Gastroenterology and Hepatology, doctors found that certolizumab pegol - another type of biologic therapy - effectively maintains remission of Crohn's disease for up to 18 months.
-
Continuous maintenance therapy with certolizumab pegol is more likely to produce response and remission than interrupted therapy, without negatively impacting patient safety.
PhysOrg.com - latest science and technology news stories 2010
-
More patients in the drug-interruption group developed antibodies against certolizumab pegol and had lower plasma concentrations of certolizumab pegol than the continuously treated group.
PhysOrg.com - latest science and technology news stories 2010
-
Humira (adalimumab), Cimzia (certolizumab pegol), and Simponi (golimumab).
-
Patients who completed PRECiSE 2 were eligible to enter PRECiSE 3, an ongoing, open-label extension trial in which patients have received certolizumab pegol every four weeks for a total of 80 weeks.
PhysOrg.com - latest science and technology news stories 2010
-
Humira (adalimumab), Cimzia (certolizumab pegol), and Simponi (golimumab).
-
Subcutaneous certolizumab pegol administered every four weeks is an effective and well-tolerated, long-term maintenance therapy for patients with moderate to severe Crohn's disease.
PhysOrg.com - latest science and technology news stories 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.